期刊文献+

2009~2013年齐齐哈尔市粪肠球菌基因序列进化研究及耐药性分析 被引量:5

An evolutionary study of the gene sequences and drug resistance of Enterococcus faecalis in Qiqihar from 2009 to 2013
原文传递
导出
摘要 目的研究化脓性胆管炎患者胆汁培养粪肠球菌基因序列,分析其对6种氟喹诺酮类药物的耐药性。方法对2009~2013年齐齐哈尔医学院附属三院ERCP治疗的化脓性胆管炎患者胆汁标本分离的60株粪肠球菌进行基因序列分析,并利用琼脂稀释法检测分离菌对6种氟喹诺酮类药物(FQs)的MIC50,MIC90和耐药率。结果本组粪肠球菌对6种氟喹诺酮类药物耐药率分别为:莫西沙星15.0%,加替沙星18.3%,左氧氟沙星25.0%,氧氟沙星和环丙沙星均为35.0%,诺氟沙星48.3%。粪肠球菌耐药株中的gyrA在喹诺酮类药物耐药决定区的第83位和87位氨基酸发生突变,分别为S83I,E87G。parC第80位氨基酸发生突变S80I,产生对氟喹诺酮类药物耐药。结论莫西沙星和加替沙星对粪肠球菌具有良好的抑制作用,但由于部分粪肠球菌菌株基因已发生突变,其耐药性还需进一步观察,同时还需开发更有效的具有抑制此类细菌DNA促旋酶和拓扑异构酶Ⅳ的氟喹诺酮类药物。 Objectives To study the gene sequences of Enterococcus faecalis in cultures of bile from patients with suppurative cholangitis and to analyze resistance to 6fluoroquinolones(FQs). Methods The gene sequences of 60strains of E.faecalis were analyzed.These strains were isolated from patients at the Third Hospital Affiliated with Qiqihar Medicine University in Qiqihar from 2009-2013.The MIC50,MIC90,and rate of drug resistance to 6FQs were determined using the agar dilution method. Results Resistant strains had mutations of amino acid 83and amino acid 87in the quinolone resistance-determining regions(QRDRs)of the gyrA gene(S83Iand E87G,respectively).Mutation of amino acid 80(S80I)in the ParC gene produced drug resistance to FQs.E.faecalis had resistance to moxifloxacin of15%,resistance to gatifloxacin of 18.3%,resistance to levofloxacin of 25%,resistance to ofloxacin and ciprofloxacin of35%,and resistance to norfloxacin of 48.3%. Conclusion Moxifloxacin and gatifloxacin satisfactorily inhibited E.faecalis but there were mutations of genes in some strains.The drug resistance of E.faecalis still needs to be monitored,and new FQs need to be developed to inhibit the DNA gyrase and topoisomerase IV genes of this bacterium.
出处 《中国病原生物学杂志》 CSCD 北大核心 2014年第4期322-326,共5页 Journal of Pathogen Biology
关键词 化脓性胆管炎 粪肠球菌 氟喹诺酮类药物 耐药性 氨基酸 Enterococcus faecalis fluoroquinolone resistance amino acid
  • 相关文献

参考文献17

  • 1Clinical and Laboratory Standards Institute (CLS1). Performancestandards for Antimicrobial Susceptibility testinj?[S]. NineteenthInformational Supplement. Clinical and Laboratory Standards In-stitute, 2009, 29(3): 100-19.
  • 2Kobaya.shi CC\ Sadoyania (;,Vieira Jl). et al. Associated anti-microbial resistance in Knterococcus spp. clinical isolates[J]. RevSoc Bras Med Trop, 2011 . 44: 341_8.
  • 3vSzymanska E. -Markuszowski M J. C'apron X. t、t al. Increasingconclusiveness of metabonomic studies by cheminformatic prepro-cessing of capillary electrophoretic data on urinary nucleoside pro-files[J]. Pharm Biomed Anal,2007,43(2) : 413 - 20.
  • 4Vergidis PI. Falagas ME. New antibiotic agents for blood streaminfectiona[J]. Int J Antimicrob Agents, 2008,32(Suppll) : 60 -5.
  • 5Koh WJ,Kwon ()J,Gwak H, et al. Daily 300 mg dose of linezol-id for the treatment of intractable multidrug. Resistant and exten-sively drag-resistant tuberculosis[J]. J Antimicrob Chemother,2009,64: 388 - 91.
  • 6Schaberg D R, Dillon W I,Terpenning M S,et al. Increasing re-sistance of enterococci to ciprofloxacin [J]. Antimicrob AgentsChemother, 1992,36( 11) : 2533 - 5.
  • 7Tankovic J,Mahjoubi F,Courvalin P, et al. Development of fluoroquinolone resistance in Enterococcus faecalis and role of mu-tations in the DNA gyrase gyrA gene [J]. Antimicrob AgentsChemother, 1996, 40(13 ) : 2558 - 61.
  • 8王进,李家泰,李耘.氟喹诺酮类抗菌药物对2554株细菌的抗菌活性分析[J].中国抗感染化疗杂志,2004,4(1):14-17. 被引量:28
  • 9刘兴态,汪华,曾蓉,李玉梅.肠球菌的耐药性监测[J].实用医技杂志,2006,13(19):3404-3404. 被引量:1
  • 10林健梅,杨兴祥,喻华,乔宁,黄仁刚,江南.葡萄球菌和肠球菌耐药监测[J].寄生虫病与感染性疾病,2012,10(4):192-194. 被引量:2

二级参考文献15

共引文献28

同被引文献56

  • 1Gil RG, Gomez MPR, Arias AG, et al. Nosocoial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital[J3. Diagn Microbio Infect Dis, 2009, 65(2): 175-9.
  • 2Souli M, Sakka V, Galani I, et al. Colonisation with vancomycin and linezolid-resistant Enterococcus faeciumin a university Lin- ezolidresistant Hospital molecular epidemiology and risk factor a- nalysis[J]. Int J Antimicrob Agents, 2009, 33(2) : 137-42.
  • 3Bader MS, Hawboldt J, Brooks A. Management of complicated u- rinary tract infections in the era of antimicrobial resistance[J]. Postgrand Med, 2010, 122(6): 7-15.
  • 4Rybak JM, Barber KE, Rybak MJ. Current and prospective treat ments for multidrugresistant grampositive infections[J]. Expert ()pin Pharmacother, 2013, 14(14): 1919-32.
  • 5Huckabee CM, Huskins WC, Murray PR. Predicting clearance of colonization with van-comycin-resistant Enterococci and Methi- cillimresistant Staphylococcus aureus by use of weekly surveil- lance Cultures[J]. J ClinMicrobiol, 2009, 47(1): 1229-30.
  • 6Boehr DD, Daigle DM, Wright GD. Domain-domain interactions in the aminoglycoside antibiotic resistance enzyme AAC (6)-APH (2)[J]. Biochemistry, :)004, 43(30): 9846-55.
  • 7Draker KA, Wright GD. Molecular mechanism of the enterococ- cal aminoglycoside 6 N acetyl transferase: role of GNAT con- served residues in the chemistry of antibiotic inactivation [J]. Bi- ochemistry, 2004, 43(2): 446-54.
  • 8Douthwaite S, Hansen LH, Mauvals P. Macrolide ketolide inhi- bition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA[J]. Mol Microbiol, 2000, 36(1): 183.
  • 9Shankar N, Baghdayan AS, Willems R, et al. Presence of patho- genicity island genes in Enterococcus faecalis isolates from pigs in Denmark[J]. J Clinical Microbiol, 2006, 144(11): 4200-3.
  • 10Behnood A, Farajnia S, Moaddab SR, et al. Prevalence of aac (6')-Ie-aph(2H)-Ia resistance gene and its linkage t'tic resistance genes and mobile genetic elements in activited sludge[J]. PLoS One, 2011, 6(10): e26041.

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部